IMF Launches New Education Initiative

Submitted by blackswan on Fri, 03/16/2018 - 01:07

This week, the IMF is launching a new initiative to provide current recommendations for myeloma management for the busy physicians, pharmacists, and nurses who are on the frontlines of providing patient care. The impetus for the initiative is the recognition that community health care providers need, and value, up-to-date expert recommendations delivered in convenient formats over a variety of platforms—video, online, in print, and in person.

How the DNA sequence of a rare bird can give us hope

Submitted by blackswan on Thu, 03/08/2018 - 13:30

Budget cuts to programs aimed at protecting people from toxic exposure, investigating climate change, and accelerating scientific discoveries continue to raise concerns. Fortunately, there are also some amazing scientific developments on the horizon that should make us all hopeful. But first, the bad news, because it’s important to keep on top of issues that impact our lives.

The Importance of Having a Plan

Submitted by blackswan on Fri, 02/17/2017 - 05:09

When a myeloma treatment or research plan comes together, it can be a great achievement. But it is unlikely to occur by chance. The goals and options need to be laid out very carefully ahead of time.

Why expertise is important in guiding treatment planning, myeloma research, and much more

Submitted by blackswan on Fri, 02/10/2017 - 04:56

A new book, “The Death of Expertise: The Campaign Against Established Knowledge and Why it Matters,” highlights the disconcerting rise in anti-expertise sentiment in the U.S. In the era of Wikipedia and Google, everyone can be his or her own “expert.” The bounty of information available is a positive development. But the notion that experts can be wrong and therefore cannot be trusted is a dangerous one.

Global Collaboration Essential to Achieve a Cure for Myeloma

Submitted by blackswan on Thu, 02/02/2017 - 23:42

“Our primary objective is to cure myeloma by preventing malignant transformation in patients at risk.” Those are the words of Bruno Paiva, principal investigator of our Black Swan Research Initiative® (BSRI) project in Pamplona, Spain. To truly achieve this, the 200-plus members of the International Myeloma Working Group (IMWG) are collaborating on and implementing multiple research projects around the world.

Pages